Belgian hadron therapy consortium
Belgian hadron therapy consortium reported total assets of 78,917 € at the end of the 2024 financial year (annual accounts filed with the NBB on 28 Jul 2025).
The score of Belgian hadron therapy consortium shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2024
Change 2021 → 2024: Equity -14 % Total assets -12 %
Accounts of the company itself (not consolidated).
The full file covers 4 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Belgian hadron therapy consortium's annual accounts
Filed annual accounts
- Year ended 31 Dec 2024filed on 28 Jul 2025
- Year ended 31 Dec 2023filed on 24 Jul 2024
- Year ended 31 Dec 2022filed on 06 Jul 2023
- Year ended 31 Dec 2021filed on 16 Dec 2022
Belgian hadron therapy consortium's financial analysis
Management and control of Belgian hadron therapy consortium
11 active director(s) in the register.
and 5 more
Belgian hadron therapy consortium's shareholders and holdings →Belgian hadron therapy consortium's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0890.078.631
- VAT number
- BE0890078631
- Peppol
- Not found on Peppol as of 10 Nov 2026 · Check
- Incorporated
- 30 May 2007
- Registered office
- 1160 Auderghem
- Latest accounts
- 2024 · filed on 28 Jul 2025
Belgian hadron therapy consortium has been based in Auderghem since 2007, active in: —. For 2024, it reports a net loss of 606 € and equity of 63,649 €; its revenue is not published.
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Belgian hadron therapy consortium
Companies in the same business, of comparable size and area, outside its group.
- Private Stichting Angela Merici Antwerp · balance sheet 78,885 €
- Het Broeifonds Wervik · balance sheet 78,495 €
- OWS Research Foundation Sint-Martens-Latem · balance sheet 32,055 €
- Ruelens - van Gorp Foundation for Dystonia Research Knokke-Heist · balance sheet 23,999 €
- Fondation TADAM pour la prise encharge médicale des troubles liés aux substances psycho-actives et pour le soutien de la recherche en matière de trait Liège · balance sheet 345,862 €
- Stichting Edith Devriendt Ghent · balance sheet 383,684 €
- Bram'S Foundation Buying and selling of own real estate Linter · balance sheet 15,418 €
- Gigot Nicolas Esneux · balance sheet 12,708 €
Frequently asked questions about Belgian hadron therapy consortium
What is the revenue of Belgian hadron therapy consortium?
Belgian hadron therapy consortium files its accounts in a format where revenue is optional: it is not published for 2024.
What is the VAT number of Belgian hadron therapy consortium?
In Belgium, the VAT number is the company number prefixed with BE: BE0890078631 for Belgian hadron therapy consortium, if the company is VAT-registered. Its company number (CBE) is 0890.078.631.
Where is the registered office of Belgian hadron therapy consortium?
According to the CBE register, the registered office of Belgian hadron therapy consortium is in 1160 Auderghem.
What is the equity of Belgian hadron therapy consortium?
At the close of the 2024 financial year, the equity of Belgian hadron therapy consortium amounts to 63,649 €, a solvency of 80.7% of total assets.
Who manages Belgian hadron therapy consortium?
The register lists 11 active mandates at Belgian hadron therapy consortium. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Belgian hadron therapy consortium
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →